Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Gemfibrozil)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000923 AN001514 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease The Broad Institute Abundance
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut peak area
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut peak area
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida Peak area
ST001708 AN002782 Oxylipin biosynthesis reinforces cellular senescence through a RAS/p53 feedback loop and allows detection of senolysis Blood Mouse Buck Institute for Research on Aging Peak area
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology Peak area
ST000248 AN000392 Metabolic heterogeneity in Glioblastoma Glioma cells Human Cancer University of Florida Peak height
ST000286 AN000455 Mouse skeletal myotube chronic low-frequency stimulation Myotubes Mouse University of Florida Peak height
ST000294 AN000471 Mechanisms of Metabolic Cycles in Diapausing Flesh Fly by Metabolomics Approach Whole insect Flesh Fly University of Florida Peak height
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000666 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000670 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST000045 AN000075 Plasma metabolomics: Comparison of non-diabetic controls with T1D patients Blood Human Mayo Clinic Raw MS Intensities
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
  logo